Is this why Neil Woodford loves tobacco and healthcare stocks?

Tobacco and healthcare stocks offer superb defensive characteristics and this could be a key reason why Neil Woodford has been a major investor in them

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One of the big stories of the last six months has been the high level of volatility in global stock markets. For example, the FTSE 100 was trading at 6,417 points six months ago, has been as low as 5,536 since then and is now almost back to where it started at over 6,400. Looking ahead, it would be little surprise if such volatility continued, with US interest rate rises on the horizon and Chinese growth prospects being rather uncertain.

In the face of such high volatility, predictability can be a valuable commodity. On this front, tobacco and healthcare stocks have proved popular among many notable investors, including Neil Woodford. In fact, he has said that his biggest mistake during his investment career has been to have too little exposure to the tobacco sector.

A key reason for the popularity of those two sectors could be that they’re less positively correlated to the returns of the wider index. In other words, they’re less cyclical than most of their index peers and have historically offered strong returns over a long period even if the wider economy or stock market is enduring a challenging period. For example, British American Tobacco is up by 8% in the last six months, while GlaxoSmithKline is up by the same amount during the same time period.

Certainly, those two companies are performing relatively well as businesses and this is a key reason why their shares are up by more than the FTSE 100’s 3% fall in the same time period. However, the key takeaway is that their performance could have been equally strong in a boom or a bust. They offer relative predictability over a long period since their revenue is less reliant upon the performance of the wider economy.

What’s the appeal

Tobacco is relatively unaffected by recessions or boom periods since individuals smoke regardless of their financial outlook. Clearly, they may cut back somewhat during tough times, but with global smoker numbers increasing each year and tobacco companies having tremendous pricing power, the outlook for the sector is highly appealing, even though regulations are getting tougher worldwide.

Similarly, pharmaceutical companies are reliant upon the development of new drugs in order to increase sales and profitability. Such development is less closely linked to the economic cycle than for most companies and so it could be argued that healthcare stocks provide not only the prospect of high returns, but also welcome diversification, too.

So, while buying shares in cyclical firms can mean high capital gains in the long run, tobacco and healthcare stocks could offer more reliable and consistent gains. As such, they seem to be worth buying and appear to be especially valuable during periods of uncertainty.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of British American Tobacco and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£10,000 invested in Games Workshop shares 5 years ago is now worth…

Despite inflation, higher interest rates, and a cost of living crisis, Games Workshop shares have gone from strength to strength…

Read more »

Investing Articles

How much in a Stocks and Shares ISA could earn me £500 of passive income each month?

Christopher Ruane does the maths and explains how he's trying to generate hundreds of pounds per month in passive income…

Read more »

Investing Articles

Prediction: 2 UK shares that could outperform Rolls-Royce between now and 2030

Away from the FTSE 100 and the FTSE 250, Stephen Wright thinks there are some UK shares with outstanding growth…

Read more »

Investing Articles

Can easyJet soar like the Rolls-Royce share price?

Harvey Jones is looking for FTSE 100 stocks that can match the success of the Rolls-Royce share price. Budget carrier…

Read more »

Investing Articles

Is there any growth potential left in Tesla stock?

Tesla stock has shot up 85% in less than three months. Christopher Ruane shares his take on the firm's valuation…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Can Taylor Wimpey rocket like the IAG share price?

The IAG share price smashed the FTSE 100 last year but Harvey Jones thinks it may struggle to repeat that…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Here’s how a stock market beginner could get going in 2025 with £260!

Christopher Ruane explains how a stock market novice could start buying shares for the first time this year with just…

Read more »

Investing Articles

Games Workshop share price falters on half-year results as fears of US tariffs loom

The Games Workshop share price suffered a dip this morning after releasing interim results. Is there more room for growth…

Read more »